Subgroup analyses in confirmatory clinical trials: time to be specific about their purposes

被引：0
|
作者：
Julien Tanniou
Ingeborg van der Tweel
Steven Teerenstra
Kit C. B. Roes
机构：
[1] UMC Utrecht,Julius Center for Health Sciences and Primary Care
[2] College ter Beoordeling van Geneesmiddelen,Department of Health Evidence, Section Biostatistics
[3] Dutch Medicines Evaluation Board,undefined
[4] Radboud University Medical Centre,undefined
来源：
BMC Medical Research Methodology | / 16卷
关键词：
Clinical trials; Subgroups; Subgroup analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Frailty in clinical drug trials: Frailty assessments, subgroup analyses and outcomes
    Nguyen, Tu N.
    Ahmad, Fahed
    Lindley, Richard I.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2025, 91 (01) : 8 - 22
  • [42] Race and Subset Analyses in Clinical Trials: Time to Get Serious About Data Integration
    Polite, Blase N.
    Sylvester, Brooke E.
    Olopade, Olufunmilayo I.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (20) : 1486 - U6
  • [43] Subgroup-specific dose finding in phase I clinical trials based on time to toxicity allowing adaptive subgroup combination
    Chapple, Andrew G.
    Thall, Peter F.
    PHARMACEUTICAL STATISTICS, 2018, 17 (06) : 734 - 749
  • [44] Randomised controlled trials: subgroup analyses
    Sedgwick, Philip
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [45] Re: Views of American oncologists about the purposes of clinical trials - Response
    Joffe, S
    Weeks, JC
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (08) : 631 - 631
  • [46] Challenges with sex-specific subgroup analyses in oncology clinical trials for drug approvals between 2015-2020
    Jenei, Kristina
    Raymakers, Adam
    Meyers, Daniel E.
    Prasad, Vinay
    JOURNAL OF CANCER POLICY, 2021, 30
  • [47] Characteristics of post hoc subgroup analyses of oncology clinical trials: a systematic review
    Alrawabdeh, Jawad
    Alzu'bi, Marah
    Alzyoud, Muntaser
    Odeh, Nada
    Hamadneh, Yazan
    Mian, Hira
    Mohyuddin, Ghulam Rehman
    Kelkar, Amar H.
    Goodman, Aaron M.
    Chakraborty, Rajshekhar
    Russler-Germain, David A.
    Mehra, Nikita
    Baggio, Diva
    Cliff, Edward R. Scheffer
    Al Hadidi, Samer
    JNCI CANCER SPECTRUM, 2023, 7 (06)
  • [48] Covariate adjustment in subgroup analyses of randomized clinical trials: A propensity score approach
    Yang, Siyun
    Li, Fan
    Thomas, Laine E.
    Li, Fan
    CLINICAL TRIALS, 2021, 18 (05) : 570 - 581
  • [49] Analyzing clinical trials - Subgroup, stratified, and intermediate analyses, and composite outcome criteria
    Duval, Xavier
    PRESSE MEDICALE, 2007, 36 (03): : 519 - 523
  • [50] Interaction effects and subgroup analyses in clinical trials: more than meets the eye?
    Sevdalis, Nick
    Jacklin, Rosamond
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2008, 14 (05) : 919 - 922
12345